CAS 263251-78-1

Tavilermide

CAS : 263251-78-1

Tavilermide

Degré de pureté : ≥98%

Masse moléculaire : 580.54g/mol

Ref: 54-BUP22178

Tavilermide

CAS : 263251-78-1

Tavilermide is a conjunctival diagnostic agent that is used to identify inflammatory diseases. It is also an anti-inflammatory agent. Tavilermide has been shown to have a safety profile and to be effective in relieving symptoms of certain inflammatory diseases, such as ocular and nasal allergies, asthma, eczema, and dermatitis. Tavilermide is a conjugate of tyrosine kinase inhibitor peptides with glycoconjugates. The presence of the glycoconjugates increases the half-life and bioavailability of the active substances in the eye. This allows for less frequent dosing than other diagnostic agents.

Formule : C₂₄H₃₂N₆O₁₁

Degré de pureté : Min. 98 Area-%

Masse moléculaire : 580.54 g/mol

Ref: 3D-NKA25178

Tavilermide

CAS : 263251-78-1

Tavilermide (MIM-D3) is a selective TrkA agonist, a cyclic mimetic, which can be used to study dry keratoconjunctivitis and dry eye syndrome.

Formule : C₂₄H₃₂N₆O₁₁

Degré de pureté : 98.98%

Couleur et forme : Solid

Masse moléculaire : 580.54

Ref: TM-T17000